C: Use with warning if benefits outweigh pitfalls. Animal research show possibility and human studies not available or neither animal nor human studies completed. Observe Closely (1)pentobarbital will lessen the level or outcome of tofacitinib by influencing hepatic/intestinal enzyme CYP3A4 metab